Post Categories
Blog post not found!
Research Breakthrough: Antibodies for the Quantification of Amyloid Beta Oligomers in Alzheimer’s Disease
Researchers have designed an antibody that can identify toxic particles that destroy healthy brain cells. A collaboration of scientists from the University of Cambridge,…
Research Breakthrough: Antibodies for the Quantification of Amyloid Beta Oligomers in Alzheimer’s Disease
June 22, 2020
Researchers have designed an antibody that can identify toxic particles that destroy healthy brain cells. A collaboration of scientists from the University of Cambridge,…
Proteomic Analysis Studies in Alzheimer’s Disease and Cerebral Atherosclerosis Research
RNA sequencing studies of thousands of post mortem human brain samples have generated massive datasets for use in medical research. These studies implicate many…
Proteomic Analysis Studies in Alzheimer’s Disease and Cerebral Atherosclerosis Research
June 15, 2020
RNA sequencing studies of thousands of post mortem human brain samples have generated massive datasets for use in medical research. These studies implicate many…
FDA Guidance Documents for COVID-19
COVID-19 was declared a global pandemic on March 11, 2020. As the novel coronavirus continues to dominate headlines and impact communities around the globe,…
FDA Guidance Documents for COVID-19
June 10, 2020
COVID-19 was declared a global pandemic on March 11, 2020. As the novel coronavirus continues to dominate headlines and impact communities around the globe,…
Protein Shapes in Alzheimer’s Disease Research
Proteins — large molecules made up of amino acids — do most of the work in cells and are required for the structure, function,…
Protein Shapes in Alzheimer’s Disease Research
June 8, 2020
Proteins — large molecules made up of amino acids — do most of the work in cells and are required for the structure, function,…
Early Detection of Alzheimer’s Disease Through exRNA Biomarkers
Alzheimer’s Disease (AD), a progressive neurodegenerative disease, is estimated to affect around 50 million people worldwide. AD is most prevalent in North America and…
Early Detection of Alzheimer’s Disease Through exRNA Biomarkers
June 1, 2020
Alzheimer’s Disease (AD), a progressive neurodegenerative disease, is estimated to affect around 50 million people worldwide. AD is most prevalent in North America and…
Can Llama Antibodies Help Fight SARS-CoV-2?
Winter is a llama who lives on a farm in Ghent, Belgium — and she may be a vital figure in the fight against…
Can Llama Antibodies Help Fight SARS-CoV-2?
May 28, 2020
Winter is a llama who lives on a farm in Ghent, Belgium — and she may be a vital figure in the fight against…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…
Visited 1 times, 1 visit(s) today